"Therapy of the short bowel syndromeBPC 157 and esophageal, gastric, small and large intestine anastomosis." Journal of Physiology Paris
Case example : A patient receives venipuncture for lab draw
Limitations of Anecdotal Evidence Community experience has fundamental limitations that deserve acknowledgment
"Or we can decline to engage, cede the ground of the gray market, deny patient choice, and give up the chance to understand these compounds well enough to use them safely and to advance our understanding of human health along the way." In recent years, peptides like BPC-157, KPV, TB-500, MOTS-C, emideltide, epitalon and Semax have been produced in a legal gray area
What exists is a growing body of preclinical data, early-phase human research, and a developing clinical consensus among peptide-prescribing physicians that points toward a relatively narrow therapeutic window
We continuously strive to provide professional care that exceeds expectations and creates positive outcomes for every client we serve